// App-Quantinova.ai

PB2108 : Elevated Von Willebrand Factor Antigen and Activity Levels Are Risk Factors for Predicting Thrombosis in Cancer

Researchers

Presenter

  • B. Yan

Principal Investigators

  • W. Du

  • T. Hu

  • Y. Zhao

  • C. Ruan

Medical Centers

  • Nanyang Central Hospital, Laboratory of Hematology, Nanyang, China

  • The First Affiliated Hospital of Soochow University, Suzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Gastric Cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved